Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Effect of the alkyl group in the piperazine N-substitution on the therapeutic action of rifamycins: A drug-membrane interaction study
Publication

Publications

Effect of the alkyl group in the piperazine N-substitution on the therapeutic action of rifamycins: A drug-membrane interaction study

Title
Effect of the alkyl group in the piperazine N-substitution on the therapeutic action of rifamycins: A drug-membrane interaction study
Type
Article in International Scientific Journal
Year
2018
Authors
Lage, EV
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Magalhaes, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pinheiro, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Salette Reis
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 289
Pages: 75-80
ISSN: 0009-2797
Publisher: Elsevier
Other information
Authenticus ID: P-00Q-E7Y
Abstract (EN): In this work, we studied the effects of the N-alkyl group (methyl, cyclopentyl) in the piperazine ring of, respectively, rifampicin (RIF) and rifapentine (RPT) to correlate this substitution with their differential pharmacokinetic properties and overall clinical performance. Since this group is their only structural change, and given that they share the same pharmacological target, differences in their therapeutic behavior may respond to this asset, particularly in their interaction with lipid membranes across the organism. In this study, surface pressure-area isotherms, as well as spectroscopic and microscopic techniques of characterization of phospholipid monolayers at the air/water interface were used to gain insight into drug-membrane interactions. Differences in the affinity for lipid membranes for both drugs, given by the vibration frequency of characteristic chemical groups in the lipid, as well as by reflectivity and mean molecular area of the monolayer, seem to be due to the N-alkyl substituent and can contribute to provide a molecular explanation as why they pose different choices in the chemotherapy against the deadliest infectious disease, tuberculosis.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Water and methanolic extracts of Salvia officinalis protect HepG2 cells from t-BHP induced oxidative damage (2007)
Article in International Scientific Journal
Cristovao F Lima; Patricia C R Valentao; Paula B Andrade; Rosa M Seabra; Manuel Fernandes Ferreira; Cristina Pereira Wilson
The Role of Mitochondrial Dysfunction and Calcium Dysregulation in 2C-I and 25I-NBOMe-Induced Neurotoxicity (2025)
Article in International Scientific Journal
Gil-Martins, E; Cagide, F; Borer, A; Barbosa, DJ; Fernandes, C; Chavarria, D; Fernando Remiao; Borges, F; Silva, R
Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies (2014)
Article in International Scientific Journal
Renata Silva; Helena Carmo; Vania Viras Boas; Daniel Jose Barbosa; Andreia Palmeira; Emilia Sousa; Felix Carvalho; Maria de Lourdes Bastos; Fernando Remiao
Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites (1999)
Article in International Scientific Journal
Casadevall, M; Fresco, PD; Kortenkamp, A
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-21 at 20:40:11 | Privacy Policy | Personal Data Protection Policy | Whistleblowing